NSETrading Window55m ago · 25 Sept 2026, 05:43 pm
Trading Window
Solara Active Pharma Sciences Limited · SOLARA
✦ AI Summary
Solara Active Pharma Sciences Limited has informed the Exchange regarding the closure of the trading window due to the SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ending September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
SOLARA_25092026174212_SE_Letter_final.pdf
View document text
Corporate Office:
Solara Active Pharma Sciences Limited
TICEL Bio Park, 6th Floor,
Module No. 601, 602, 603, Phase II – CSIR Road,
Taramani, Chennai, Tamil Nadu – 600113.
Tel: +91 44 4344 6700
Fax: +91 44 47406190
E-mail: investors@solara.co.in
Website: www.solara.co.in
Date: September 25, 2026
The BSE Limited The National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla
Dalal Street, Mumbai – 400 001 Complex, Bandra (E), Mumbai – 400 051
Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1
Dear Sir / Madam,
Subject: Intimation regarding closure of Trading Window
In accordance with the Company’s Code of Conduct for Prohibition of Insider Trading and in
compliance of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (“SEBI
PIT Regulations”) the Trading Window for dealing in the securities of the Company shall be closed
with effect from Thursday, October 1, 2026, till 48 hours from the date of declaration of financial
results of the Company for the quarter and half year ending September 30, 2026.
The date of Board Meeting for declaration of financial results of the Company for the quarter and
half year ending September 30, 2026 will be intimated in due course.
We request you to take the above information on your records.
Thanking You,
Yours Faithfully,
For Solara Active Pharma Sciences Limited
Pooja Jaya Kumar
Company Secretary and Compliance Officer
ICSI Membership No: A57415
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636
Registered Office: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703 / Tel: +91- 22-20870033